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Succinylcholine is a commonly used depolarizing neuromuscular blocking agent 
in anesthesia for relaxation of the skeletal muscles during endotracheal 
intubation.
It is ideal for use in shorter surgical cases and situations where a rapid 
sequence intubation is warranted due to its quick onset and short duration of 
action. 
One documented side effects of succinylcholine is postoperative myalgia, which 
was first described in the literature in 1952. 
An 88 y.o. male presented two days following transurethral resection of a 
bladder mass with complaints of diffuse myalgias that were severely limiting 
activity. 
The pain was greatly exacerbated by any active use of the muscles and was 
worse in the hip and shoulder girdles. 
Vital signs were normal. Labs were notable for:
• potassium 5.8 
• creatinine 2.02




However, CK, CRP and ESR were only mildly elevated and the diffuse nature of 
his pain was less consistent with these conditions. 
Given recent surgery, succinylcholine-induced postoperative myalgia was 
considered the likely culprit. The patient was managed supportively, with 
rapid improvement of his pain over the next few days. By hospital day 5, the 
myalgias had completely resolved and the patient was able to resume his 
regular activity. 
He was subsequently discharged home in good condition.
Although succinylcholine-induced postoperative myalgia is generally mild and self-limited, certain cases can be severe. 
The incidence reportedly ranges from 1.5-89%. Oftentimes, the clinical presentation is vague and complaints are 
similar to those seen in rhabdomyolysis, compartment syndrome, or polymyalgia rheumatica. Characteristics of 
postoperative myalgia pain includes:
• pain similar to that following intense physical exertion
• presenting the day following surgery
• higher frequency in females
• less common in children as well as those over 50-60 years old
• localization primarily in the neck, shoulder, and upper abdominal muscles
The incidence and severity is lower in those who are more physically active at baseline, as well as those who 
ambulate earlier following surgery. Interestingly, it also appears to occur more often in those who are undergoing 
less invasive surgical operations. Those who present with postoperative myalgias tend to have higher potassium 
levels, likely related to release of intracellular potassium. CK on the other hand does not seem to correlate with the 
development of myalgias. 
The mechanism behind postoperative myalgias is not definitively elucidated, but is thought to be related to the 
fasciculations that occur soon after succinylcholine is administered. These fasciculations lead to shearing forces that 
damage the muscle fibers, as the muscles are not contracting synchronously as a unit. Studies have shown that 
there does not appear to be an inflammatory compnenet to the pain.
This case outlines the importance of considering a broad differential for common chief complaints. In patients who 
present with severe myalgias following surgery, intraoperative succinylcholine use is an important factor that should 
be investigated. 
If diagnosed early, one can avoid potentially invasive and unnecessary workup for more serious causes of myalgias. 
1. Wong, S. F., and F. Chung. "Succinylcholine‐associated postoperative myalgia." Anaesthesia 55.2 (2000): 144-152.
2. Schreiber, Jan-Uwe, et al. "Postoperative myalgia after succinylcholine: no evidence for an inflammatory 
origin." Anesthesia & Analgesia 96.6 (2003): 1640-1644.
3. Pace NL. Prevention of succinylcholine myalgias: a meta- analysis. Anesth Analg 1990;70:477–83.
4. Payne-Leeson, C. G., G. J. Hobbs, and J. M. V. Nicoll. "Use of ketorolac in the prevention of suxamethonium myalgia." 
(1994): 788-790.
5. Crawford JS. Suxamethonium muscle pains and pregnancy. British Journal of Anaesthesia 1971; 43: 677±80. 
6. Riding, J. E. "Minor complications of general anaesthesia." British Journal of Anaesthesia 47.2 (1975): 91-101.
